肠易激综合征诊断标准从罗马III更新至罗马IV对临床特征和关键病理生理因素的影响
该研究纳入542名符合罗马III标准的瑞典肠易激综合征患者,以近10天腹痛天数≥2天作为罗马IV阳性的替代判定标准。结果显示85%的罗马III患者符合罗马IV标准,且罗马IV阳性者女性更多、生活质量更差、疼痛更重、腹胀、躯体化、疲劳及直肠敏感性更高。焦虑抑郁严重程度、IBS亚型、排便习惯不满意度和口肛传输时间无差异,腹痛天数与症状及内脏高敏感正相关。
要点
- 85%的罗马III肠易激综合征患者符合罗马IV标准,15%不符合。
- 罗马IV阳性者较阴性者女性比例更高、生活质量更差、疼痛和腹胀更重。
- 罗马IV阳性者躯体化、疲劳和直肠敏感性更高,但焦虑抑郁严重程度无差异。
核心结论
- 大多数因肠易激综合征就诊且符合罗马III标准的患者也符合罗马IV标准,且罗马IV阳性者构成一个病情更严重的群体。
- 随着腹痛天数增加,症状和内脏高敏感呈正相关。
研究设计与样本
- 研究纳入542名符合罗马III标准的瑞典肠易激综合征受试者,完成基线问卷询问近10天腹痛天数,以0或1天腹痛判定为罗马IV阴性、≥2天腹痛判定为罗马IV阳性,比较两组人口学、IBS亚型、胃肠和心理症状、躯体化、疲劳、疾病特异性生活质量、直肠敏感性和口肛传输时间。
主要发现
- 85%的罗马III肠易激综合征患者符合罗马IV标准,15%不符合。
- 罗马IV阳性者较罗马IV阴性者显著更可能为女性、生活质量更差、疼痛严重度更高、腹胀更重、躯体化更重、疲劳更重、直肠敏感性更高。
- 两组在焦虑或抑郁严重程度、IBS亚型、排便习惯不满意度或口肛传输时间方面无差异。
- 腹痛天数增加与症状和内脏高敏感呈正相关。
关键数值与推荐
- 罗马III标准要求每月至少3天慢性腹痛或腹部不适,罗马IV标准删除了「不适」一词并将腹痛频率提高至每周至少1天。
- 罗马IV阳性的替代判定标准为近10天中腹痛天数≥2天,罗马IV阴性为0或1天。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The diagnostic criteria for irritable bowel syndrome (IBS) have recently been updated from Rome III to Rome IV. Whereas in Rome III a diagnosis of IBS entailed chronic abdominal pain or discomfort at least 3 days per month, in Rome IV the term discomfort has been removed and the frequency of abdominal pain increased to at least 1 day per week. We examined how this change in IBS criteria impacts on clinical characteristics and pathophysiological factors. METHODS: A total of 542 Swedish subjects with Rome III IBS completed a baseline questionnaire enquiring for the number of abdominal pain days in the last 10 days; this was subsequently used as a surrogate marker to identify Rome IV IBS, in that (a) those with 0 or 1 day of pain were classed as Rome IV-negative, and (b) those with ≥2 days of pain were classed as Rome IV-positive. Comparisons were made between Rome IV-positive and -negative IBS groups for demographics, IBS subtype, gastrointestinal and psychological symptoms, somatisation, fatigue, disease-specific quality of life, rectal sensitivity, and oro-anal transit time. RESULTS: Overall, 85% of Rome III IBS patients fulfilled the Rome IV criteria for IBS, but 15% did not. Rome IV-positive subjects were significantly more likely to be female, have poorer quality of life, greater pain severity, bloating, somatisation, fatigue, and rectal sensitivity than Rome IV-negative subjects. There were no differences in severity of anxiety or depression, IBS subtypes, bowel habit dissatisfaction, or oro-anal transit time. Finally, increasing number of pain days correlated positively with symptoms and visceral hypersensitivity. CONCLUSIONS: Most Rome III-positive IBS patients seeking healthcare fulfil the Rome IV IBS criteria. They constitute a more severe group than those who lose their IBS diagnosis.
引用
- Aziz I, Törnblom H, Palsson OS, et al. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. Am J Gastroenterol. 2018. PMID: 29880963. doi:10.1038/s41395-018-0074-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。